Overview
What is Plasma Protein Therapeutics Assoc?
The Plasma Protein Therapeutics Assoc (PPTA) is a nonprofit association headquartered at 147 Old Solomons IS Rd, Annapolis, MD, 21401. Established in 1994, PPTA represents the interests of the plasma collection and fractionation industry by advocating for regulatory, legislative, and public policy issues on a global scale. With a workforce of approximately 31 individuals, PPTA staff collaborates with governmental institutions and regulatory agencies worldwide to monitor regulatory activities, coordinate industry positions, and develop strategic initiatives that enhance the industry's regulatory environment. PPTA advocates and promotes safe and effective plasma protein therapeutics, ensuring broad and reliable access to high-quality plasma protein therapies, with a focus on the well-being of patients and plasma donors. Notably, PPTA developed the Patient Notification System, a free, confidential, 24-hour communication system providing up-to-date information on plasma-derived and recombinant product withdrawals and recalls in North America.
Official website here: www.pptaglobal.org
Is Plasma Protein Therapeutics Assoc legitimate?
Plasma Protein Therapeutics Assoc is a legitimate nonprofit organization registered as a 501(c)(6) entity. Plasma Protein Therapeutics Assoc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $933,931
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,707,804
For more financial information, click here
Official website here: www.pptaglobal.org
What is the mission statement of Plasma Protein Therapeutics Assoc?
The Plasma Protein Therapeutics Assoc (PPTA) advocates for the safety and effectiveness of plasma protein therapies, prioritizing the well-being of patients and plasma donors. PPTA represents the plasma collection and fractionation industry on regulatory, legislative, and other public policy matters, working cooperatively with governmental institutions and regulatory agencies worldwide. They monitor regulatory and policy activities and coordinate industry positions on existing, new, and emerging issues, defining and developing strategic initiatives to enhance the industry's regulatory environment. The association speaks with one voice on association and member programs, founded in 1994, and is the primary advocate for leading producers of plasma-based and related recombinant biological therapeutics. PPTA Europe, formed from the European Association of the Plasma Products Industry (EAPPI), acts as the principal interlocutor with regulatory authorities on a national and European level and with national governments, committed to being involved in all discussions relevant to the plasma therapeutics industry and the patients who depend on the medicines produced by their members. PPTA also manages the Patient Notification System, a free, confidential, 24-hour communication system providing information on plasma-derived and recombinant product withdrawals and recalls in North America.
Official website here: www.pptaglobal.org
Who is the CEO of Plasma Protein Therapeutics Assoc?
Eugene Stroshane is the Sr Vp Public of Plasma Protein Therapeutics Assoc.
Official website here: www.pptaglobal.org
What is the revenue of Plasma Protein Therapeutics Assoc?
Plasma Protein Therapeutics Assoc's revenue in 2022 was $16,106,524.
Official website here: www.pptaglobal.org
Who are the executives of Plasma Protein Therapeutics Assoc and what are their salaries?
The average compensation at Plasma Protein Therapeutics Assoc during 2022 was $85,217. There are 31 employees at Plasma Protein Therapeutics Assoc.
Here are 14 key members and their salaries:
- Compensation: $408,544
- Related: $0
- Other: $31,010
- Compensation: $358,633
- Related: $0
- Other: $45,646
- Compensation: $341,993
- Related: $0
- Other: $36,784
- Compensation: $263,926
- Related: $0
- Other: $29,003
- Compensation: $245,242
- Related: $0
- Other: $45,157
- Compensation: $235,509
- Related: $0
- Other: $37,271
- Compensation: $226,611
- Related: $0
- Other: $31,690
- Compensation: $183,384
- Related: $0
- Other: $74,058
- Compensation: $214,865
- Related: $0
- Other: $37,944
- Compensation: $204,065
- Related: $0
- Other: $44,538
- Compensation: $161,693
- Related: $0
- Other: $43,255
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.pptaglobal.org
Where can I find the form 990 for Plasma Protein Therapeutics Assoc?
Plasma Protein Therapeutics Assoc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.pptaglobal.org
Learn more at the official website: www.pptaglobal.org
Mission Statement of Plasma Protein Therapeutics Assoc
Plasma Protein Therapeutics Assoc (PPTA), an influential organization, advocates tirelessly for the promotion and safety of plasma protein therapies. With a mission rooted in patient welfare and donor well-being, PPTA drives broad and reliable access to these essential treatments (Paraphrased from: activityOrMissionDesc and missionDesc).
PPTA represents the interests of the plasma collection and fractionation industry on a global scale. Its staff work cooperatively with regulatory agencies and governments around the world, staying informed of regulatory and policy activities. They coordinate industry positions on existing, new, and emerging issues, and develop strategic initiatives to enhance the industry's regulatory environment (Paraphrased from: desc).
The association speaks with one voice on association and member programs. Founded in 1994, PPTA Europe, formerly the European Association of the Plasma Products Industry (EAPPI), is the primary advocate for leading plasma-based and related recombinant biological therapeutics producers. Through its working groups, PPTA Europe develops industry-wide consensus positions and initiatives. Acting as the principal interlocutor with regulatory authorities on a national and European level and with national governments, PPTA Europe is involved in all discussions directly relevant to the plasma therapeutics industry and the patients who depend on the medicines produced by its members. (Paraphrased from: missionDesc and desc)
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Plasma Protein Therapeutics Association (PPTA) plays a crucial role in advocating for the plasma protein therapeutics industry, ensuring that patients have access to safe and effective treatments. By representing the interests of plasma collection and fractionation, PPTA works collaboratively with regulatory authorities and governmental bodies around the world to influence public policy and regulatory frameworks.
PPTA monitors and engages with various legislative and regulatory matters, including those related to the U.S. Congress, the European Commission, the World Health Organization, and numerous national agencies. This proactive stance allows the association to coordinate industry positions, address emerging issues, and develop strategic initiatives that enhance the regulatory environment, benefiting both patients and plasma donors.
Additionally, PPTA is instrumental in the Patient Notification System, a free and confidential information resource that keeps consumers informed about plasma-derived and recombinant product withdrawals and recalls. This initiative originated from collaborative efforts with producers, distributors, and consumers, and serves to ensure transparency and accountability within the industry.
Founded in 1994, PPTA Europe has also established itself as a key advocate for leading producers of plasma-based therapies in Europe, fostering dialogue with regulatory authorities and advancing initiatives that prioritize patient well-being.
In summary, PPTA drives access to high-quality plasma protein therapies, underscoring its commitment to the health and safety of patients dependent on these important medicines.
This information is meant to be a general summary of Plasma Protein Therapeutics Assoc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $58,770
- Program Service Revenue: $16,047,754
- Gross Receipts: $16,106,524
Assets and Liabilities:
- Total Assets: $10,684,709
- Total Liabilities: $2,287,926
- Net Assets: $8,396,783
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
MEMBER DUES
Revenue
$8,055,438
NDDR
Revenue
$5,697,774
CERTIFICATION
Revenue
$1,424,445
FORUMS
Revenue
$418,640
PATIENT NOTIFICATION
Revenue
$352,028
Organization Details
Founding Year
1992
Phone
(443) 458-4676Principal Officer
Eugene Stroshane
Main Address
147 OLD SOLOMONS IS RD STE 100, ANNAPOLIS, MD, 21401
Website
www.pptaglobal.orgNTEE Category
Code: S41 - Community improvement
If you are a representative of Plasma Protein Therapeutics Assoc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.